HomeOpen Access NewsDrug Development

Drug Development

UHCW to lead trial of new device to address miscarriage symptoms

University Hospitals Coventry and Warwickshire (UHCW) NHS Trust is to lead a clinical trial of a novel device aimed at addressing miscarriage symptoms.

Universal COVID vaccines can learn from the common cold

Research shows that T cells, created by the common cold, can give some protection against COVID - which means that universal vaccines can mimic this technology.

COVID vaccine can cause temporary change to menstruation cycle

Scientists analysed 23,754 menstrual cycles to find that menstruation can be temporarily, harmlessly changed - by taking two mRNA vaccines during the same cycle.

FDA approves new long-lasting drug for HIV prevention

December saw monumental steps being taken in HIV prevention with the FDA approving their first approval of long-acting HIV prevention medication.

Scientists to identify depression and antidepressant efficiency via blood tests

Researchers at the University of Chicago are believed to be one step closer in the development of blood tests to identify depression.

Convidecia vaccine 57.5% effective against symptomatic COVID

Phase Three trial shows Convidecia vaccine 57.5% effective against symptomatic COVID, while 91.7% effective against severe COVID.

Getting personal in brain tumour therapy: Matching therapies to patients

Sean E. Lawler PhD from Brown University Cancer Center, an experienced scientist in the brain tumour field

Metformin: A possible new treatment for endometriosis

Dr Deborah Lee, Dr Fox Online Pharmacy, discusses a possible new treatment for endometriosis - the condition that impacts atleast 1.5 million women in the UK.

New Pfizer Covid-19 pill seeking emergency use authorization from FDA

Pfizer have announced that it is seeking emergency use authorization for its new Covid-19 oral antiviral candidate PAXLOVID™

How to compete with COVID-19 with a computer?

Y-h. Taguchi, Professor at Chuo University in Japan, reveals how to compete with COVID-19 by using a computer.

Pfizer COVID-19 pill 89% effective against death

Pfizer has announced that its antiviral pill, PAXLOVID, is 89% effective in reducing COVID-19 hospitalisation and death.

New “clickable” COVID vaccine patch in early stages of testing

The University of Texas is creating a COVID vaccine patch, which can protect against the virus - without the use of a needle.

UK creates deal for 480,000 doses of Merck COVID pill

The Merck COVID pill, molnupiravir, cuts risk of death by 50% - now, the UK have secured 480,000 doses for late 2021.

New cancer treatment creates best “overall survival ever”

A new cancer treatment, an immunotherapy combination as opposed to gruelling chemotherapy, is saving the lives of head and neck cancer patients.

Neuromodulation clears symptoms of severe, untreatable depression

Targeted neuromodulation may be a future method to help those with severe, untreatable depression - traditionally, this is used to correct misfiring brain circuits in people with epilepsy or Parkinson's.

Changing the treatment paradigm in Inflammatory Bowel Diseases

Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, explains why drug-candidate ABX464 has the potential to address the urgent need for new, safe short- and long-term effective drugs to treat Inflammatory Bowel Diseases.

Glycoscience offers opportunities galore in healthcare

Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explains how glycoscience offers opportunities galore in healthcare.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders